chr20-51788963-C-G
Variant names:
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1
The NM_020436.5(SALL4):c.2640G>C(p.Ser880Ser) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.117 in 1,614,150 control chromosomes in the GnomAD database, including 12,275 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.088 ( 811 hom., cov: 32)
Exomes 𝑓: 0.12 ( 11464 hom. )
Consequence
SALL4
NM_020436.5 synonymous
NM_020436.5 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -5.38
Genes affected
SALL4 (HGNC:15924): (spalt like transcription factor 4) This gene encodes a zinc finger transcription factor thought to play a role in the development of abducens motor neurons. Defects in this gene are a cause of Duane-radial ray syndrome (DRRS). Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Dec 2015]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.78).
BP6
Variant 20-51788963-C-G is Benign according to our data. Variant chr20-51788963-C-G is described in ClinVar as [Benign]. Clinvar id is 261263.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr20-51788963-C-G is described in Lovd as [Benign].
BP7
Synonymous conserved (PhyloP=-5.38 with no splicing effect.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.132 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SALL4 | NM_020436.5 | c.2640G>C | p.Ser880Ser | synonymous_variant | Exon 3 of 4 | ENST00000217086.9 | NP_065169.1 | |
SALL4 | NM_001318031.2 | c.1329G>C | p.Ser443Ser | synonymous_variant | Exon 3 of 4 | NP_001304960.1 | ||
SALL4 | XM_047440318.1 | c.2334G>C | p.Ser778Ser | synonymous_variant | Exon 3 of 4 | XP_047296274.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SALL4 | ENST00000217086.9 | c.2640G>C | p.Ser880Ser | synonymous_variant | Exon 3 of 4 | 1 | NM_020436.5 | ENSP00000217086.4 | ||
SALL4 | ENST00000395997.3 | c.1329G>C | p.Ser443Ser | synonymous_variant | Exon 3 of 4 | 1 | ENSP00000379319.3 | |||
SALL4 | ENST00000371539.7 | c.309G>C | p.Ser103Ser | synonymous_variant | Exon 2 of 3 | 1 | ENSP00000360594.3 |
Frequencies
GnomAD3 genomes AF: 0.0877 AC: 13341AN: 152168Hom.: 811 Cov.: 32
GnomAD3 genomes
AF:
AC:
13341
AN:
152168
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0916 AC: 23021AN: 251444Hom.: 1317 AF XY: 0.0945 AC XY: 12842AN XY: 135906
GnomAD3 exomes
AF:
AC:
23021
AN:
251444
Hom.:
AF XY:
AC XY:
12842
AN XY:
135906
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.120 AC: 175852AN: 1461864Hom.: 11464 Cov.: 32 AF XY: 0.119 AC XY: 86581AN XY: 727234
GnomAD4 exome
AF:
AC:
175852
AN:
1461864
Hom.:
Cov.:
32
AF XY:
AC XY:
86581
AN XY:
727234
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0876 AC: 13339AN: 152286Hom.: 811 Cov.: 32 AF XY: 0.0863 AC XY: 6426AN XY: 74466
GnomAD4 genome
AF:
AC:
13339
AN:
152286
Hom.:
Cov.:
32
AF XY:
AC XY:
6426
AN XY:
74466
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:3
-
PreventionGenetics, part of Exact Sciences
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing
- -
-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance: Benign
Review Status: no assertion criteria provided
Collection Method: clinical testing
- -
-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance: Benign
Review Status: no assertion criteria provided
Collection Method: clinical testing
- -
not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: not provided
- -
Mar 03, 2015
GeneDx
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing
- -
Duane-radial ray syndrome Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at